UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026
ACCESSWIRE•22/10/2026•09:00 ET
0
Key Highlights
- ➤3Q revenue $8.621M, down 12.1% year over year
- ➤3Q operating income $2.795M, up 7.0% year over year
- ➤9M revenue $25.873M, down 12.2% year over year
- ➤2026 sales projection: full-year decline close to 7%
- ➤Cash and investments $85.2M; no debt at September 30
SALT LAKE CITY, UT / ACCESS Newswire / October 22, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2026 financial results that include changes from the prior year's same period results.
Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted.
Get started
Create a free account to read the full story.